丽珠肠乐（回春生）对肝硬化的疗效观察  

CLINICAL OBSERVATION OF THE THERAPEUTIC EFFECT OF LI-ZHU-CHANG-LE ON LIVER CIRRHOSIS

作　　者：李春梅[1] 王超[1] 张成有[1] 姜虹[1] 黄天卫[1] 

机构地区：[1]大连医科大学附属第一医院消化内科

出　　处：《中国微生态学杂志》1994年第2期21-23,共3页Chinese Journal of Microecology

摘　　要：丽珠肠乐（回春生）为双歧杆菌活菌制剂，给７３例肝硬化失代期病人口服２２～６７天。治疗前后分别检测血内毒素含量及肝功能，观察其疗效。结果表明本制剂对肝硬化的疗效明显，总有效率为７９．４５％，其中内毒素水平治疗后明显下降，与治疗前比较，Ｐ＜０．０１，有效率为８７．６７％。肝功能各指标有不同程度的改善，有效率７８．０８％。说明回春生是当代最新的微生态调节剂。Li-Zhu-Chang-Le, an agent of vital bifidobacteria,was adminis-tered orally to 73 patients with decompensated liver cirrhosis for 22-67 daysBlood endotoxin concentration and liver functions were tested before and after the administration respectively in order to abserve the thera-paeutic effect of this drug.The results showed that this agent was ob-viously effective in the treatment of liver cirrhosis and the totol effective rate was 79.45%,The endotoxin concentration was significantly decrea-sed after the adlninistration(P<0.01),and the effective rate was 87.67%.The liver function were improved to different extents,and the effective rate was 78.08%. Those results suggest that Li-Zhu Chang-Le is the newest micrec tiological regulntor nowdays.

关 键 词：肝硬化 双歧杆菌活菌制剂 内毒素血症 肝功能 

分 类 号：R259.7[医药卫生—中西医结合]